alendronate has been researched along with icariin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagatin, D; Bagatin, T; Fureš, R; Jeleč, Ž; Kukolj, M; Nemrava, J; Odeh, D; Oršolić, N; Terzić, S | 1 |
| Ha, TTM; Lai, TT; Nguyen, HVM; Pham, CV; Pham, TT; Phuong, TT; To, TT; Tran, LD; Trinh, DC; Winkler, C | 1 |
2 other study(ies) available for alendronate and icariin
| Article | Year |
|---|---|
The Beneficial Effect of Proanthocyanidins and Icariin on Biochemical Markers of Bone Turnover in Rats.
Topics: Alendronate; Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Female; Flavonoids; Proanthocyanidins; Rats | 2018 |
Icariin reduces bone loss in a Rankl-induced transgenic medaka (Oryzias latipes) model for osteoporosis.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Disease Models, Animal; Etidronic Acid; Fish Diseases; Flavonoids; Organisms, Genetically Modified; Oryzias; Osteoporosis; RANK Ligand | 2021 |